Real-life experience with benralizumab during 6 months

Padilla-Galo, A; Levy-Abitbol, R; Olveira, C; Azcona, BV; Morales, MP; Rivas-Ruiz, F; Tortajada-Goitia, B; Moya-Carmona, I; Levy-Naon, A

Padilla-Galo, A (corresponding author), Agencia Sanitaria Costa Sol, Pneumol Unit, 4th Floor,Carretera Nacl 340,Km 187, Malaga 29603, Spain.

BMC PULMONARY MEDICINE, 2020; 20 (1):

Abstract

Background Benralizumab is a monoclonal antibody that binds to the human interleukin-5 (IL-5) receptor (IL-5R), thereby preventing IL-5 from binding t......

Full Text Link